• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Drug Policy and Law
  • Harm Reduction
  • Activism

Drugreporter

News and Films from the Frontline of the War on Drugs

  • News
  • Café
  • Videos
  • About Us
  • EN
    • HU
    • RU

Why Was Ibogaine Banned in Hungary?

May 11, 2015 | Author: Péter Sárosi

Tweet

The Hungarian government banned 42 new psychoactive substances this year – but some of them are not new at all, for example Ibogaine. The Hungarian Civil Liberties Union is suing a government agency for not providing access to the assessment reports on the risks of these drugs.   

This January, the Hungarian government added 42 new psychoactive substances to the schedule of illicit drugs. Most of these substances are produced in Chinese laboratories and transported to Europe to provide legal substitutes – such as  amphetamine-type stimulants and synthetic cannabinoids – for currently illegal drugs. There are some odd substances, however, among those banned, which do not meet the definition of new psychoactive substances – for the simple reason that they are not new psychoactive substances. One example is salvinorin-A, the active psychoactive ingredient found in the plant salvia divinorum. This plant is native to the Sierra Mazateca in Oaxaca, Mexico, where it has been used by the Mazatec for centuries, primarily to procure shamanic visions, in the context of healing or divination. The use of salvia has been documented in Hungary since at least the 90s, though mainly restricted to a small group of psychonauts. Its use is not without risk: it’s a powerful plant, and if you use it in an inappropriate context (set and setting), it can lead to bad trips. There is no proof of its addictive potential or long-term harms; what is more, there is research to suggest that it has therapeutic value in the treatment of addiction.  

Another odd-one-out in the list is ibogaine, the substance found in plants of the apocynaceae family, such as tabernanthe iboga. Another psychedelic drug that has been used for centuries – in this case, by tribes in Gabon, Africa, where the Bwiti religion regard it as a sacrament.  During the colonial era, French colonists and their Catholic missionaries persecuted all forms of traditional ibogaine use, but now it is regarded as part of Gabon’s cultural heritage. It also has therapeutic potential in the treatment of drug addiction: it’s not a miracle drug, but a number of heroin users have kicked their habit with the help of ibogaine-assisted psychotherapy (learn more!). One of the best-known activists advocating for the legal use of ibogaine in addiction treatment, is Dimitri Mugianis, who was a heroin user himself but stopped use after being treated in an ibogaine clinic in the Netherlands. Ibogaine is clearly not a drug of abuse: no recreational user would have fun with, and get addicted to, a drug which can induce severe vomiting lasting for 24 hours.


I am dangerous with love (excerpts from the movie on Dimitri and Ibogaine) 

How, and why, have these drugs come to be listed as new psychoactive substances? The government created a temporary list of new psychoactive substances in 2012, in order to speed up and simplify the process of bringing drugs under control. The Minister of Human Resources (this is the ministry of labour, welfare and health in Hungary) updates this so called Schedule-C every three to four months. The National Addiction Centre (OAC) is charged with producing a risk assessment report for each individual substance on Schedule-C, with the help of professional advisers. Based on this risk assesment, the government decided to classify these 42 substances as illicit drugs. In the course of the risk assesement process, the professionals are supposed to observe whether the drug has any therapeutic potential, and whether it poses a public health threat comparable to that posed by illegal drugs. But the risk-assessment documents have not been published, so we cannot know what arguments and literature were used to substantiate the claim that substances such as salvinorin-A or ibogaine have no medical value and high potential for abuse.

The Hungarian Civil Liberties Union submitted a Freedom of Information request to the National Addiction Centre, in order to obtain the risk-assessment documents, but the Centre refused access, claiming that any publicity would endanger the professional quality of work. We are now suing the Centre for a violation of the constitutional right to freedom of information, arguing that these documents are public data, because they serve as  the basis for criminal sanctions, and their publication is therefore in the public interest. The Hungarian Constitutional Court has previously made it clear that "the convenience of persons and agencies serving a public interest does not override the fundamental right to information" – that is to say, authorities should provide access to public data even when this is inconvenient for public servants. It may take a year or two, but we are confident that the justice system will ultimately decide in our favour.

Greater knowledge of the risk assessment procedure is also important because we would like to know more about the country's policy responses to new psychoactive substances. Two years ago, we produced a survey of professionals in a number of European countries, which showed that the majority of respondents were very sceptical about the current "ban-as-much-as-possible-as-fast-as-possible" approach to new drugs. When Schedule-C was first introduced, in 2012, the government heralded it as a 'silver bullet' solution to the problem of 'legal highs'. Now, three years later, it is clear that the process has failed to reduce the availability of new drugs – on the contrary, it has made the drug market even more dangerous than before! Banning new drugs keeps the drug market in a state of permanent change: substances are replaced, within a few months, by new substances with unknown psychoactive effects and dosage, giving rise to a constant stream of overdoses and hospitalisations. In many parts of the country, synthetic cannabinoid products have supplanted natural cannabis, because they are cheaper to produce and (until they are banned) it is legal to sell them. Drug designers are always a step ahead of policy-makers. Instead of pursuing the unachievable utopia of a drug-free society, we should be considering market regulation, and alternatives to punitive drug policies.

Peter Sarosi     

Filed Under: Articles Topics: Drug Policy and Law, European Drug Policy, New Psychoactive Substances, Psychedelic Medicines, Regulation and Control

Access to this article is free - but to produce articles and videos is not. Drugreporter is a non-profit website that needs your support to provide you with high quality contents.

Become a supporter and make a donation of 5 $ today!

Kapcsolódó cikkek:

The Italian Anti-Rave Law Violates Human Rights – Interview with Susanna Ronconi

February 1, 2023 - Péter Sárosi

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Kapcsolódó videók:

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Harm Reduction in Athens – With the Eye of an Outsider

November 23, 2022 - Péter Sárosi

You can browse our topics here:

Activism COVID-19 Criminalisation Dose of Science Drug Consumption Rooms Drug Policy and Law European Drug Policy Harm Reduction Hepatitis HIV/AIDS Marijuana Policies Medical Marijuana Needle and syringe programs New Psychoactive Substances Opiate Substitution Overdose Prevention Psychedelic Medicines Regulation and Control Russian Drug Policy Sex Work United Nations Drug Policy US Drug Policy

Primary Sidebar

BECOME A SUPPORTER OF DRUGREPORTER! INVEST THE PRICE OF A COFFEE MONTHLY AND MAKE SURE DRUGREPORTER KEEPS RUNNING!
Subscribe to the Newsletter!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Facebook
  • Twitter
  • YouTube

Search

Drugreporter Video Database

Hundreds of videos on drug policy, harm reduction and human rights for streaming and download, also on a world map!

DRUGREPORTER NEWS

Monthly drug policy news from around the world

Drugreporter café

In our new online video show, we regularly discuss new developments in the world of drug policy with professionals, activists and decision makers. You can also listen to the Drugreporter Café in Podcast format on Spotify or Apple Podcasts!

COVID-19 Harm Reduction Update

On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.

Drugreporter Video Advocacy Network

Browse videos produced by members of our Drugreporter Video Advocacy Network, from all around the world!

DRUG USERS NEWS

Russian language videos on drug policy, harm reduction and human rights.

Our award winning animated documentary movie is based on the original audio recording of Kostya Proletarsky, a drug user and HIV activist who died as a result of mistreatment and torture at a Russian prison. Festival appearances, news and resources are available here!

Footer

Rights Reporter Foundation
Hungary, 1032 Budapest
San Marco Street 70.
Email: rightsreporter@rightsreporter.net

Search

Our other websites:

The Rights Reporter Foundation

The Autocracy Analyst

Room for Change Campaign

Room in the 8th District Campaign

A Day in the Life movie website

Drugreporter